Cargando…

Viral persistence in colorectal cancer cells infected by Newcastle disease virus

BACKGROUND: Newcastle disease virus (NDV), a single-stranded RNA virus of the family Paramyxoviridae, is a candidate virotherapy agent in cancer treatment. Promising responses were observed in clinical studies. Despite its high potential, the possibility of the virus to develop a persistent form of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chia, Suet-Lin, Yusoff, Khatijah, Shafee, Norazizah
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4030049/ https://www.ncbi.nlm.nih.gov/pubmed/24886301 http://dx.doi.org/10.1186/1743-422X-11-91

Ejemplares similares

Newcastle Disease Virus Hemagglutinin Neuraminidase as a Potential Cancer Targeting Agent
por: Baradaran, Ali, et al.
Publicado: (2016)

Recombinant Enterovirus 71 Viral Protein 1 Fused to a Truncated Newcastle Disease Virus NP (NPt) Carrier Protein
por: Mustafa, Suhaili, et al.
Publicado: (2020)

Reduced Newcastle disease virus-induced oncolysis in a subpopulation of cisplatin-resistant MCF7 cells is associated with survivin stabilization
por: Jamal, Mohd-Hafifi, et al.
Publicado: (2012)

Persistent Newcastle disease virus infection in bladder cancer cells is associated with putative pro-survival and anti-viral transcriptomic changes
por: Chan, Lee-Chin, et al.
Publicado: (2021)

Analysis of PPI networks of transcriptomic expression identifies hub genes associated with Newcastle disease virus persistent infection in bladder cancer
por: Ahmad, Umar, et al.
Publicado: (2023)

Newcastle disease virus degrades HIF-1α through proteasomal pathways independent of VHL and p53
por: Abd-Aziz, Noraini, et al.
Publicado: (2016)

Immunization with recombinant enterovirus 71 viral capsid protein 1 fragment stimulated antibody responses in hamsters
por: Ch’ng, Wei-Choong, et al.
Publicado: (2012)

Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy
por: Lam, Han Yuen, et al.
Publicado: (2011)

In-Vitro and In-Silico Evaluations of Heterocyclic-Containing Diarylpentanoids as Bcl-2 Inhibitors Against LoVo Colorectal Cancer Cells
por: Leong, Sze Wei, et al.
Publicado: (2020)

Evaluation of a Recombinant Newcastle Disease Virus Expressing Human IL12 against Human Breast Cancer
por: Mohamed Amin, Zahiah, et al.
Publicado: (2019)

Corrigendum to “Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy”
por: Lam, Han Yuen, et al.
Publicado: (2017)

Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus
por: Yusoff, Khatijah, et al.
Publicado: (1988)

Exploring the Prospects of Engineered Newcastle Disease Virus in Modern Vaccinology
por: Bello, Muhammad Bashir, et al.
Publicado: (2020)

Oncolytic effects of the recombinant Newcastle disease virus, rAF-IL12, against colon cancer cells in vitro and in tumor-challenged NCr-Foxn1nu nude mice
por: Syed Najmuddin, Syed Umar Faruq, et al.
Publicado: (2020)

Knockdown of the Autophagy Protein Beclin-1 Does Not Affect Innate Cytokine Production in Human Lung Epithelial Cells during Respiratory Syncytial Virus Infection
por: Parameswaran, Kavesha, et al.
Publicado: (2023)

Diagnostic and Vaccination Approaches for Newcastle Disease Virus in Poultry: The Current and Emerging Perspectives
por: Bello, Muhammad Bashir, et al.
Publicado: (2018)

Cytotoxicity study of the interleukin-12-expressing recombinant Newcastle disease virus strain, rAF-IL12, towards CT26 colon cancer cells in vitro and in vivo
por: Najmuddin, Syed Umar Faruq Syed, et al.
Publicado: (2020)

The matrix (M) protein of newcastle disease virus binds to human bax through its BH3 domain
por: Molouki, Aidin, et al.
Publicado: (2011)

Immunomodulatory Effects of Newcastle Disease Virus AF2240 Strain on Human Peripheral Blood Mononuclear Cells
por: Lam, Han Yuen, et al.
Publicado: (2014)

Metabolic Reprogramming in Colon Cancer Cells Persistently Infected with Newcastle Disease Virus
por: Yu, Tong, et al.
Publicado: (2023)

Genotype Diversity of Newcastle Disease Virus in Nigeria: Disease Control Challenges and Future Outlook
por: Bello, Muhammad Bashir, et al.
Publicado: (2018)

Purification of recombinant nucleocapsid protein of Newcastle disease virus from unclarified feedstock using expanded bed adsorption chromatography
por: Tan, Yan Peng, et al.
Publicado: (2006)

Rapid Generation of a Recombinant Genotype VIII Newcastle Disease Virus (NDV) Using Full-Length Synthetic cDNA
por: Murulitharan, Kavitha, et al.
Publicado: (2021)

Evaluation of Ultra-Microscopic Changes and Proliferation of Apoptotic Glioblastoma Multiforme Cells Induced by Velogenic Strain of Newcastle Disease Virus AF2240
por: Ali-Saeed, Rola, et al.
Publicado: (2019)

Application of Newcastle disease virus in the treatment of colorectal cancer
por: Song, Hui, et al.
Publicado: (2019)

Newcastle disease virus selectively infects dividing cells and promotes viral proliferation
por: Chu, Zhili, et al.
Publicado: (2019)

The Viral Knock: Ameliorating Cancer Treatment with Oncolytic Newcastle Disease Virus
por: Pathak, Upasana, et al.
Publicado: (2023)

A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread
por: Brown, Vienna R., et al.
Publicado: (2017)

Correction to: A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread
por: Brown, Vienna R., et al.
Publicado: (2017)

Development of an Effective and Stable Genotype-Matched Live Attenuated Newcastle Disease Virus Vaccine Based on a Novel Naturally Recombinant Malaysian Isolate Using Reverse Genetics
por: Bello, Muhammad Bashir, et al.
Publicado: (2020)

STUDIES ON PERSISTENT INFECTIONS OF TISSUE CULTURES : V. THE INITIAL STAGES OF INFECTION OF L(MCN) CELLS BY NEWCASTLE DISEASE VIRUS
por: Rodriguez, José E., et al.
Publicado: (1964)

A novel peptide inhibits the influenza virus replication by preventing the viral attachment to the host cells
por: Rajik, Mohamed, et al.
Publicado: (2009)

Effect of Immunosuppression on Newcastle Disease Virus Persistence in Ducks with Different Immune Status
por: Njagi, Lucy W., et al.
Publicado: (2012)

Bortezomib attenuates HIF-1- but not HIF-2-mediated transcriptional activation
por: ABD-AZIZ, NORAINI, et al.
Publicado: (2015)

Design and Characterization of Viral Polypeptide Inhibitors Targeting Newcastle Disease Virus Fusion
por: Zhu, Jieqing, et al.
Publicado: (2005)

Patterns of RNA Editing in Newcastle Disease Virus Infections
por: Jadhav, Archana, et al.
Publicado: (2020)

Newcastle Disease Virus at the Forefront of Cancer Immunotherapy
por: Burman, Bharat, et al.
Publicado: (2020)

Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis
por: Kalyanasundram, Jeevanathan, et al.
Publicado: (2015)

Newcastle Disease Virus: A Promising Vector for Viral Therapy, Immune Therapy, and Gene Therapy of Cancer
por: Schirrmacher, Volker, et al.
Publicado: (2008)

Genetic diversity of Newcastle disease virus in Pakistan: a countrywide perspective
por: Shabbir, Muhammad Zubair, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7ol8vrse8ctah96r28t1489sdp